Breakdown | ||||
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.56B | 1.63B | 1.94B | 1.41B | 900.80M | Gross Profit |
399.62M | 397.21M | 469.57M | 481.38M | 337.05M | EBIT |
176.39M | 212.12M | 129.11M | 348.10M | 219.92M | EBITDA |
198.54M | 245.27M | -108.96M | 368.71M | 233.08M | Net Income Common Stockholders |
157.14M | 160.41M | -197.29M | 251.11M | 162.48M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
984.50M | 826.18M | 1.21B | 1.51B | 822.89M | Total Assets |
2.28B | 2.22B | 2.29B | 2.55B | 1.39B | Total Debt |
114.94M | 158.29M | 412.59M | 518.52M | 116.46M | Net Debt |
-845.35M | -667.89M | -796.63M | -987.66M | -706.43M | Total Liabilities |
1.13B | 1.23B | 1.50B | 1.49B | 540.03M | Stockholders Equity |
1.10B | 931.48M | 747.32M | 1.04B | 845.07M |
Cash Flow | Free Cash Flow | |||
93.52M | -108.95M | -98.54M | 505.54M | 66.43M | Operating Cash Flow |
106.01M | -105.68M | -86.34M | 531.10M | 169.91M | Investing Cash Flow |
67.93M | -50.65M | 31.09M | -225.22M | -240.61M | Financing Cash Flow |
-48.34M | -272.10M | -245.32M | 376.79M | 674.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | $23.50B | 12.07 | 4.96% | 0.36% | 1.31% | 379.84% | |
68 Neutral | HK$3.28B | 6.45 | 9.70% | 9.42% | 2.68% | 8.49% | |
67 Neutral | HK$392.18M | 3.76 | 8.37% | ― | -14.98% | -39.71% | |
60 Neutral | $2.81B | 11.04 | 0.20% | 8508.34% | 6.12% | -16.66% | |
51 Neutral | HK$243.49M | 15.44 | 1.67% | ― | -5.11% | ― | |
47 Neutral | HK$191.96M | ― | -13.24% | 14.18% | -12.47% | -30.56% | |
46 Neutral | HK$4.10B | ― | -29.17% | 3.68% | -11.94% | -756.32% |
Starjoy Wellness and Travel Company Limited, a subsidiary of Aoyuan Healthy Life Group Co. Ltd., has announced its upcoming annual general meeting (AGM) scheduled for May 27, 2025. During the AGM, the company will address several key issues, including the adoption of financial statements, declaration of a final dividend, re-election of directors, and re-appointment of auditors. Additionally, the company seeks shareholder approval for mandates to repurchase shares and issue new shares, which could impact its market operations and shareholder value.
Starjoy Wellness and Travel Company Limited reported a decrease in total revenue and net profit for the year ended December 31, 2024, primarily due to strategic adjustments and bad debt provisions. Despite the financial setbacks, the company improved its gross profit margin, reduced administrative expenses, and increased operating cash flow, indicating enhanced cost control and cash flow management. The board anticipates stabilization in financial impacts from strategic changes and recommends a final dividend payment, reflecting confidence in the company’s future sustainability and project viability.
Starjoy Wellness and Travel Company Limited has announced a final cash dividend of RMB 0.0265 per share for the financial year ending December 31, 2024. The dividend will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.0829, with a payment date set for June 20, 2025. This announcement may impact the company’s financial outlook and provide returns to shareholders, reflecting its financial performance and commitment to shareholder value.
Starjoy Wellness and Travel Company Limited, along with its subsidiaries, has issued a profit warning indicating a significant decline in profits for the year ended December 31, 2024. The company expects to record a profit of not less than RMB90.0 million, compared to approximately RMB157.1 million in the previous year. This decline is attributed to strategic business adjustments made in response to the ongoing impacts of the real estate market and economic downturn.
Starjoy Wellness and Travel Company Limited has issued a profit warning, indicating an expected decrease of up to 50% in net profit for the year ending December 31, 2024, compared to the previous year. This decline is attributed to a strategic shift from aggressive expansion to a defensive approach, focusing on existing project management due to the real estate market’s ongoing challenges and economic downturn. The company has withdrawn from low-profit, high-risk projects and made provisions for impairments on receivables, which has significantly impacted net profit. The company anticipates stabilizing performance in the next one to two years.